Modern aspects of treatment for uterine myoma (Review of foreign literature)
- Authors: Levakov S.A1, Borovkova E.I1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 2, No 1 (2015)
- Pages: 13-17
- Section: Original study articles
- URL: https://journal-vniispk.ru/2313-8726/article/view/35258
- ID: 35258
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
S. A Levakov
I.M. Sechenov First Moscow State Medical Universityд-р мед. наук, доц. каф. акушерства и гинекологии Института профессионального образования Moscow, Russian Federation, 119991
E. I Borovkova
I.M. Sechenov First Moscow State Medical University
Email: katyanikitina@mail.ru
Институт профессионального образования Moscow, Russian Federation, 119991
References
- Parker W.H. Uterine myomas: management. Fertil. and Steril. 2007; 88: 255-71.
- Alternatives to Hysterectomy in the management of leiomyomas (Am. Coll. Obstet. Gynecol. Pract. Bull. No. 96). Obstet. and Gynecol. 2008; 112: 201.
- Laughlin S.K., Hartmann K.E., Baird D.D. Postpartum factors and natural fibroid regression. Am. J. Obstet. Gynecol. 2011; 204: 496.e1.
- Wise L.A., Palmer J.R., Harlow B.L. et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am. J. Epidemiol. 2004; 159: 113-23.
- Zapata L.B., Whiteman M.K., Tepper N.K. et al. Intrauterine device use among women with uterine fibroids: a systematic review. Contraception. 2010; 82: 41-55.
- Venkatachalam S., Bagratee J.S., Moodley J. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study. J. Obstet. Gynaecol. 2004; 24: 798-800.
- Minaguchi H., Wong J.M., Snabes M.C. Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature. J. Reprod. Med. 2000; 45: 481-9.
- Surrey E.S., Hornstein M.D. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet. and Gynecol. 2002; 99: 709-19.
- Flierman P.A., Oberye J.J., van der Hulst V.P., de Blok S. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix. Br. J. Obstet. Gynaecol. 2005; 112: 638-42.
- Engman M., Granberg S., Williams A.R. et al. Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial. Hum. Reprod. 2009; 24: 1870-9.
- Bagaria M., Suneja A., Vaid N.B. et al. Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial. Aust N. Z. J. Obstet. Gynaecol. 2009; 49: 77-83.
- Mutter G.L., Bergeron C., Deligdisch L. et al. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol. 2008; 21: 591-8.
- Wilkens J., Williams A.R., Chwalisz K. et al. Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN. Hum. Reprod. 2009; 24: 1036-44.
- Wilkens J., Chwalisz K., Han C. et al. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy. J. Clin. Endocrinol. Metab. 2008; 93: 4664-71.
- Donnez J., Tatarchuk T.F., Bouchard P. et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N. Engl. J. Med. 2012; 366: 409-20.
- Donnez J., Tomaszewski J., Vazquez F. et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N. Engl. J. Med. 2012; 366: 421-32.
- Lingxia X., Taixiang W., Xiaoyan C. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. Cochrane Database Syst. Rev. 2007; 4: CD005287.
- Parsanezhad M.E., Azmoon M., Alborzi S. et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil. and Steril. 2010; 93: 192-8.
- Al-Hendy A., Lee E.J., Wang H.Q., Copland J.A. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am. J. Obstet. Gynecol. 2004; 191: 1621-31.
- Minakuchi K., Kawamura N., Tsujimura A., Ogita S. Remarkable and persistent shrinkage of uterine leiomyoma associated with interferon alfa treatment for hepatitis. Lancet. 1999; 353: 2127-8.
- Bocca S., Stadtmauer L., Oehninger S. Uncomplicated full term pregnancy after da Vinci-assisted laparoscopic myomectomy. Reprod. Biomed Online. 2007; 14: 246-9.
- Lonnerfors C., Persson J. Pregnancy following robot-assisted laparoscopic myomectomy in women with deep intramural myomas. Acta Obstet. Gynecol. Scand. 2011; 90: 972-7.
- Garza Leal J.G., Hernandez Leon I., Castillo Saenz L., Lee B.B. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System. J. Minim. Invasive Gynecol. 2011; 18: 364-71.
- van der Kooij S.M., Bipat S., Hehenkamp W.J. et al. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. 2011; 205:317.e1.
- Edwards R.D., Moss J.G., Lumsden M.A. et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N. Engl. J. Med. 2007; 356: 360-70.
- Hesley G.K., Felmlee J.P., Gebhart J.B. et al. Noninvasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging-guided focused ultrasound. Mayo Clin. Proc. 2006; 81: 936-42.
- Smart O.C., Hindley J.T., Regan L., Gedroyc W.G. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet. and Gynecol. 2006; 108: 49-54.
- Yoon S.W., Lee C., Cha S.H. et al. Patient selection guidelines in MR-guided focused ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI. Eur. Radiol. 2008; 18: 2997-3006.
- Taran F.A., Weaver A.L., Coddington C.C., Stewart E.A. Understanding adenomyosis: a case control study. Fertil. and Steril. 2010; 94: 1223-8.
- Funaki K., Fukunishi H., Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet. Gynecol. 2009; 34: 584-9.
- Gorny K.R., Woodrum D.A., Brown D. et al. Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J. Vasc. Interv. Radiol. 2011; 22: 857-64.
- Kim H.S., Baik J.H., Pham L.D., Jacobs M.A. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad. Radiol. 2011; 18: 970-6.
Supplementary files
